Antacid poisoning
Deb, S.
Pediatrics 86(2): 325
1990
ISSN/ISBN: 0031-4005 PMID: 2371111 Document Number: 362654
Document emailed within 1 workday
Related Documents
Holtermüller, K.H.; Bohlen, E.; Castro, M.; Weis, H.J. 1977: Considerations on antacid therapy Medizinische Klinik 72(30): 1229-1241Rehnström, T.; Gripenberg, M. 1992: Osteomalacia associated with antacid abuse Duodecim; Laaketieteellinen Aikakauskirja 108(12): 1127-1129
Berstad, A.; Kolstad, B. 1982: Evaluation of antacid tablets (Link "A.L") Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 102(12): 688-690
Albin, H.; Vinçon, G.; Pehourcq, F.; Dangoumau, J. 1982: Effect of an antacid on the bioavailability of cimetidine Therapie 37(5): 563-566
Rocher, I.; Henry, J.F.; Flouvat, B. 1984: The effect of antacid and aspirin on the bioavailability of isofezolac in man International Journal of Clinical Pharmacology Therapy and Toxicology 22(9): 464-469
Girotti, M.J.; Ruddan, J.; Cohanim, M. 1984: Amphojeloma: antacid impaction in a critically ill patient Canadian Journal of Surgery. Journal Canadien de Chirurgie 27(4): 379-380; 382
Borella, L.E.; DiJoseph, J.F.; Mir, G.N. 1989: Cytoprotective and antiulcer activities of the antacid magaldrate in the rat Arzneimittel-Forschung 39(7): 786-789
Desmond, P.V.; Harman, P.J.; Gannoulis, N.; Kamm, M.; Mashford, M.L. 1990: The effect of an antacid and food on the absorption of cimetidine and ranitidine Journal of Pharmacy and Pharmacology 42(5): 352-354
Sommer, H.; Kasper, H.; Herzberger, U. 1973: Steady intragastral pH measurement after application of antacid drugs Medizinische Klinik 68(46): 1500-1503
Koop, H.; Spill, W.; Schwarting, H.; Arnold, R. 1988: Influence of prolonged antacid administration on rat gastric mucosa Zeitschrift für Gastroenterologie 26(10): 643-647
Tay, H.S.; Chiu, H.H. 1978: Evaluation of pre-operative antacid for elective caesarian section Singapore Medical Journal 19(2): 78-81
Pawlaczyk, J.; Kokot, Z.; Rafińska, A. 1985: In vitro study of the antipeptic activity of antacid preparations Acta Poloniae Pharmaceutica 42(2): 153-158
Scheurlen, M. 2000: Peptic ulcer hemorrhage: i.v. antacid prevents recurrence MMW Fortschritte der Medizin 142(45): 30
Rosini, S.; Trallori, L.; Benetti, D. 1976: Anti-ulcer and antacid activity of a new cyclopentane substance Il Farmaco; Edizione Pratica 31(8): 426-435
Bianchi, P.G. 1979: Quigel: a new concept of gastric antacid and antireflux agent Minerva Dietologica E Gastroenterologica 25(4): 455-456
Bianchi, B.G. 1979: Quigel: a new antacid-anti-gastric refluc agent Minerva Dietologica E Gastroenterologica 25(1): 81-84
Nain, C.K.; Singh, K.; Dhawan, V.; Vinayak, V.K.; Ganguly, N.K. 1992: Evaluation of antacid gel preparations available commercially in the Indian market Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 13(2): 70-74
Agarwal, B.N.; Robertson, F.M. 1986: Metabolic alkalosis and hypermagnesemia following "non-absorbable" antacid therapy Delaware Medical Journal 58(8): 531-532
Moragues, J.; Beneyto, J.E.; Fábregas, J.L.; Spickett, R.G. 1984: Characterization of a new crystalline synthetic gastric antacid, almagate Arzneimittel-Forschung 34(10a): 1346-1349
Beckett, P.R.; Llupiá, J.; Lumachi, B.; Roberts, D.J. 1984: Pharmacological studies with almagate, a potent new antacid compound Arzneimittel-Forschung 34(10a): 1367-1370